Business

BrowserStack's AI Agent Cuts Test Case Creation Time by 90%

Dec 03, 2025

PRNewswire
Dublin [Ireland], December 3: BrowserStack, the world's leading software testing platform, today announced the Test Case Generator Agent, an AI-powered solution that generates production-ready test cases in under a minute.
Test case creation is one of QA's heaviest lifts. Teams spend countless hours interpreting vague inputs, uncovering edge cases, and manually crafting test scenarios. What makes it even more challenging is the chaos of fragmented requirements, scattered across Jira, Confluence, PDFs, Figma files, screenshots, and even Slack--creating confusion, missed scenarios, and painful delays.
The Test Case Generator Agent changes this. Built on 14 years of testing expertise, it analyzes fragmented requirements and instantly generates context-rich test cases, auto-filling key fields like description, preconditions, test steps, and expected results. Instead of writing from scratch, teams review, refine, and move straight to execution.
Key capabilities:
* Instant test case creation: Convert any requirement artifact including Jira stories, PRDs, images, Confluence, figma design files and more into ready-to-run test cases.
* Smarter coverage: Surfaces high-value scenarios and edge cases using signals from project testing history.
* Flexible AI-assisted workflows: Refine results with simple prompts, handle unstructured inputs, and export in BDD or multilingual formats.
"We saw QA teams drowning in manual test creation while generic AI tools fell short of real-world testing needs," said Ritesh Arora, Co-founder & CEO, BrowserStack. "That's where the Test Case Generator comes in. What takes under a minute today, we're pushing to get down to seconds. QA teams shouldn't be buried in documentation, rather be busy uncovering real issues and improving product quality. This agent gives that time back."
Early adopters report 90% faster test case creation and 50% better coverage. The Test Case Generator Agent is available now within BrowserStack Test Management, part of a growing suite of AI agents that streamline testing across the lifecycle.
About BrowserStack
BrowserStack is the world's leading software testing platform, powered by AI to help developers and QA teams deliver quality software at speed. Trusted by over 50,000 teams, including Amazon, Microsoft, and NVIDIA, BrowserStack powers more than three million tests every day across 21 global data centers. The platform gives teams instant access to over 30,000 real devices and browsers.
Founded in 2011, BrowserStack is a privately held company backed by Accel, Bond, and Insight Partners. For more information, visit https://www.browserstack.com.
Media Contact
Press Relations Team
press@browserstack.com
Logo: https://mma.prnewswire.com/media/2490455/BrowserStack_Logo.jpg
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire. ANI will not be responsible in any way for the content of the same)

More news

Study by Indian Body, Center for Chronic Disease Control Reiterates Link Between Lower Salt Intake and Reduced Hypertension & Cardiovascular Disease

New Delhi [India], December 5: A new study by the Centre for Chronic Disease Control (CCDC) for the first time concurrently estimated the daily salt and iodine consumption levels of the adult population in India and examined the effect of the World Health Organization (WHO) recommended salt intake levels on iodine levels. The study demonstrated that in India, where universal salt iodization is mandatory, a reduction in salt intake to the Government of India's National Multisectoral NCD Action Plan and WHO-recommended levels of <= 5 g/d does not compromise the level of iodine intake. This was measured by the gold standard method of collecting and analysing 24-hour urine samples for salt intake and iodine intake by measuring Urinary Iodine Concentration (UIC) and urinary iodine excretion (UIE). These findings provide strong support for the current recommendations to reduce population salt intake to prevent hypertension and cardiovascular diseases (CVD), which are rapidly increasing in India. Notably, salt reduction is unlikely to impact iodine supplementation efforts, indicating compatibility between the two interventions, which should be continuously monitored through robust surveillance. The study can be accessed here.

Dec 05, 2025